BACKGROUND: Ankle fractures are common and can be associated with severe morbidity. Risk factors for short-term adverse events and readmission after open reduction and internal fixation (ORIF) of ankle fractures have not been fully characterized. QUESTIONS/PURPOSES: The purpose of our study was to determine patient rates and risk factors for (1) any adverse event; (2) severe adverse events; (3) infectious complications; and (4) readmission after ORIF of ankle fractures. METHODS: Patients who underwent ORIF for ankle fracture from 2005 to 2012 were identified in the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP(®)) database using International Classification of Diseases, 9(th) Revision and Current Procedural Terminology codes. Patients with missing perioperative data were excluded from this study. Patient characteristics were tested for association with any adverse event, severe adverse events, infectious complications, and readmission using bivariate and multivariate logistic regression analyses. RESULTS: Of the 4412 patients identified, 5% had an adverse event. Any adverse event was associated with insulin-dependent diabetes mellitus (IDDM; odds ratio [OR], 2.05; 95% confidence interval [CI], 1.35-3.1; p = 0.001), age ≥ 60 years (OR, 1.97; 95% CI, 1.22-3.2; p = 0.006), American Society of Anesthesiologists classification ≥ 3 (OR, 1.69; 95% CI, 1.2-2.37; p = 0.002), bimalleolar fracture (OR, 1.6; 95% CI, 1.08-2.37; p = 0.020), hypertension (OR, 1.47; 95% CI, 1.04-2.09; p = 0.031), and dependent functional status (OR, 1.47; 95% CI, 1.02-2.14; p = 0.040) on multivariate analysis. Severe adverse events occurred in 3.56% and were associated with ASA classification ≥ 3 (OR, 2.01; p = 0.001), pulmonary disease (OR, 1.9; p = 0.004), dependent functional status (OR, 1.8; p = 0.005), and hypertension (OR, 1.65; p = 0.021). Infectious complications occurred in 1.75% and were associated with IDDM (OR, 3.51; p < 0.001), dependent functional status (OR, 2.4; p = 0.002), age ≥ 60 years (OR, 2.28; p = 0.028), and bimalleolar fracture (OR, 2.19; p = 0.030). Readmission occurred in 3.17% and was associated with ASA classification ≥ 3 (OR, 2.01; p = 0.017). CONCLUSIONS: IDDM was associated with an increased rate of adverse events after ankle fracture ORIF, whereas noninsulin-dependent diabetes mellitus was not. IDDM management deserves future study, particularly with respect to glycemic control, a potential confounder that could not be assessed with the ACS-NSQIP registry. Increased ASA class was associated with readmission, and future prospective investigations should evaluate the effectiveness of increasing the discharge threshold, discharging to extended-care facilities, and/or home nursing evaluations in this at-risk population. LEVEL OF EVIDENCE: Level III, prognostic study.
BACKGROUND:Ankle fractures are common and can be associated with severe morbidity. Risk factors for short-term adverse events and readmission after open reduction and internal fixation (ORIF) of ankle fractures have not been fully characterized. QUESTIONS/PURPOSES: The purpose of our study was to determine patient rates and risk factors for (1) any adverse event; (2) severe adverse events; (3) infectious complications; and (4) readmission after ORIF of ankle fractures. METHODS:Patients who underwent ORIF for ankle fracture from 2005 to 2012 were identified in the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP(®)) database using International Classification of Diseases, 9(th) Revision and Current Procedural Terminology codes. Patients with missing perioperative data were excluded from this study. Patient characteristics were tested for association with any adverse event, severe adverse events, infectious complications, and readmission using bivariate and multivariate logistic regression analyses. RESULTS: Of the 4412 patients identified, 5% had an adverse event. Any adverse event was associated with insulin-dependent diabetes mellitus (IDDM; odds ratio [OR], 2.05; 95% confidence interval [CI], 1.35-3.1; p = 0.001), age ≥ 60 years (OR, 1.97; 95% CI, 1.22-3.2; p = 0.006), American Society of Anesthesiologists classification ≥ 3 (OR, 1.69; 95% CI, 1.2-2.37; p = 0.002), bimalleolar fracture (OR, 1.6; 95% CI, 1.08-2.37; p = 0.020), hypertension (OR, 1.47; 95% CI, 1.04-2.09; p = 0.031), and dependent functional status (OR, 1.47; 95% CI, 1.02-2.14; p = 0.040) on multivariate analysis. Severe adverse events occurred in 3.56% and were associated with ASA classification ≥ 3 (OR, 2.01; p = 0.001), pulmonary disease (OR, 1.9; p = 0.004), dependent functional status (OR, 1.8; p = 0.005), and hypertension (OR, 1.65; p = 0.021). Infectious complications occurred in 1.75% and were associated with IDDM (OR, 3.51; p < 0.001), dependent functional status (OR, 2.4; p = 0.002), age ≥ 60 years (OR, 2.28; p = 0.028), and bimalleolar fracture (OR, 2.19; p = 0.030). Readmission occurred in 3.17% and was associated with ASA classification ≥ 3 (OR, 2.01; p = 0.017). CONCLUSIONS:IDDM was associated with an increased rate of adverse events after ankle fracture ORIF, whereas noninsulin-dependent diabetes mellitus was not. IDDM management deserves future study, particularly with respect to glycemic control, a potential confounder that could not be assessed with the ACS-NSQIP registry. Increased ASA class was associated with readmission, and future prospective investigations should evaluate the effectiveness of increasing the discharge threshold, discharging to extended-care facilities, and/or home nursing evaluations in this at-risk population. LEVEL OF EVIDENCE: Level III, prognostic study.
Authors: M S Mizel; H T Temple; J D Michelson; R G Alvarez; T O Clanton; C C Frey; A P Gegenheimer; S R Hurwitz; L D Lutter; M G Mankey; R A Mann; R A Miller; E G Richardson; L C Schon; F M Thompson; M L Yodlowski Journal: Clin Orthop Relat Res Date: 1998-03 Impact factor: 4.176
Authors: Nicholas S Golinvaux; Daniel D Bohl; Bryce A Basques; Michael R Baumgaertner; Jonathan N Grauer Journal: Clin Orthop Relat Res Date: 2014-09-20 Impact factor: 4.176
Authors: Mariano E Menendez; Valentin Neuhaus; Arjan G J Bot; David Ring; A Holly Johnson Journal: Foot Ankle Int Date: 2014-02-28 Impact factor: 2.827
Authors: Mikko T Ovaska; Tatu J Mäkinen; Rami Madanat; Kaisa Huotari; Tero Vahlberg; Eero Hirvensalo; Jan Lindahl Journal: J Bone Joint Surg Am Date: 2013-02-20 Impact factor: 5.284
Authors: Bryce A Basques; Matthew L Webb; Daniel D Bohl; Nicholas S Golinvaux; Jonathan N Grauer Journal: J Orthop Trauma Date: 2015-03 Impact factor: 2.512
Authors: Vasanth Sathiyakumar; Cesar S Molina; Rachel V Thakore; William T Obremskey; Manish K Sethi Journal: J Orthop Trauma Date: 2015-03 Impact factor: 2.512
Authors: Mitchell S Fourman; Joshua Adjei; Richard Wawrose; Gele Moloney; Peter A Siska; Ivan S Tarkin Journal: Injury Date: 2021-11-12 Impact factor: 2.586
Authors: René Aigner; Philipp Lechler; Christoph Kolja Boese; Benjamin Bockmann; Steffen Ruchholtz; Michael Frink Journal: Int Orthop Date: 2017-12-14 Impact factor: 3.075